We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.14B
1-Year Est. Return 139.27%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+139.27%
3 Year Est. Return
+309.04%
5 Year Est. Return
+400.83%
10 Year Est. Return
+1,509.99%
AUM
$945M
AUM Growth
-$68.5M
Cap. Flow
-$71.1M
Cap. Flow %
-7.52%
Top 10 Hldgs %
61.33%
Holding
89
New
15
Increased
7
Reduced
15
Closed
17

Top Buys

Rank Stock Value
1
CLF icon
Cleveland-Cliffs
CLF
+$6.84M
2
MU icon
Micron Technology
MU
+$6.01M
3
UBER icon
Uber
UBER
+$3.5M
4
Z icon
Zillow
Z
+$1.01M
5
WKHS icon
Workhorse Group
WKHS
+$151K

Sector Composition

Rank Sector Weight
1 Miscellaneous 25.26%
2 Communication Services 18.06%
3 Financials 17.46%
4 Technology 13.67%
5 Materials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WKHS icon
51
Workhorse Group
WKHS
$33M
$2.42M 0.26%
105
+5
+5% +$151K
BMRN icon
52
BioMarin Pharmaceuticals
BMRN
$12.5B
$2.39M 0.25%
30,953
KSS icon
53
PUT
Kohl's
KSS
$1.86B
$2.35M 0.25%
+50,000
New +$2.67M
UBER icon
54
CALL
Uber
UBER
$147B
$2.24M 0.24%
+50,000
New +$2.18M
PRAA icon
55
PRA Group
PRAA
$748M
$2.15M 0.23%
51,007
-31,041
-38% -$1.24M
CRSP icon
56
CRISPR Therapeutics
CRSP
$5.1B
$2.11M 0.22%
18,876
AMC icon
57
CALL
AMC Entertainment Holdings
AMC
$2.37B
$1.9M 0.2%
+5,000
New +$2.02M
AMZN icon
58
Amazon
AMZN
$2.67T
$1.78M 0.19%
10,840
-6,500
-37% -$1.12M
BRK.B icon
59
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.68M 0.18%
6,167
SRPT icon
60
Sarepta Therapeutics
SRPT
$2.14B
$1.45M 0.15%
15,706
-9,779
-38% -$753K
RARE icon
61
Ultragenyx Pharmaceutical
RARE
$1.28B
$1.43M 0.15%
15,885
EDIT icon
62
Editas Medicine
EDIT
$413M
$1.18M 0.13%
28,797
DAL icon
63
Delta Air Lines
DAL
$51.4B
$1.15M 0.12%
27,029
-19,682
-42% -$804K
Z icon
64
Zillow
Z
$7.2B
$881K 0.09%
+10,000
New +$1.01M
SGMO
65
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$727K 0.08%
80,650
CLLS
66
Cellectis
CLLS
$141M
$642K 0.07%
50,907
ADAP
67
DELISTED
Adaptimmune Therapeutics
ADAP
$598K 0.06%
115,602
ADVM
68
DELISTED
Adverum Biotechnologies
ADVM
$409K 0.04%
18,862
-11,882
-39% -$303K
VMEO
69
DELISTED
Vimeo
VMEO
$341K 0.04%
11,600
-8,400
-42% -$331K
BLUE
70
DELISTED
bluebird bio
BLUE
$214K 0.02%
866
WVE icon
71
Wave Life Sciences
WVE
$891M
$209K 0.02%
42,722
ABEO icon
72
Abeona Therapeutics
ABEO
$308M
$103K 0.01%
3,696
BRK.B icon
73
PUT
Berkshire Hathaway Class B
BRK.B
$1.11T
-100,000
Closed -$27.8M
GME icon
74
GameStop
GME
$10.9B
-80,000
Closed -$3.66M
IWM icon
75
PUT
iShares Russell 2000 ETF
IWM
$77.2B
-47,000
Closed -$10.8M

Similar funds

WS Management's Q3 2021 Portfolio in Review

As of Q3 2021, WS Management held 89 positions worth $945M, down 6.8% from $1.01B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

WS Management withdrew a net $71.1M in Q3 2021, closing 17 positions and reducing 15 holdings. Its most notable exit was SANTANDER CONSUMER USA HOLDINGS INC, an estimated $20.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 22% a quarter earlier, followed by Communication Services and Financials.

Against the trend, WS Management opened a new position in Cleveland-Cliffs worth $5.94M.

  • WS Management's largest Q3 2021 buy was Cleveland-Cliffs: 300,000 shares worth $5.94M.
  • WS Management added most to Micron Technology in Q3 2021, an estimated $6.01M increase.
  • WS Management's biggest Q3 2021 reduction was Freeport-McMoran, cutting an estimated $12.3M.
  • WS Management fully exited SANTANDER CONSUMER USA HOLDINGS INC in Q3 2021, selling an estimated $20.7M.
  • WS Management's ten largest holdings make up 61% of its $945M portfolio in Q3 2021.
  • WS Management opened 15 new positions and closed 17 in Q3 2021.
  • WS Management's portfolio value fell 6.8% quarter-over-quarter to $945M.

Based on WS Management's 13F filing for Q3 2021, filed 12 Nov 2021.